SCHEMBL856684

SCHEMBL856684

COCCOc1ccc(-c2ccc3[nH]ccc3c2)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB4 P30926 3/20 0.66
CHRNA3 P32297 3/20 0.66
CHRNA7 P36544 3/20 0.66
CHRNA10 Q9GZZ6 3/20 0.66
CHRNA9 Q9UGM1 3/20 0.66
NPC1 O15118 1/20 0.53
APP P05067 1/20 0.49
CHRNB2 P17787 1/20 0.48
CHRNA4 P43681 1/20 0.48
LTA4H P09960 1/20 0.47
CYP17A1 P05093 1/20 0.47
CYP11B1 P15538 1/20 0.47
CYP11B2 P19099 1/20 0.47
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA9 Q16790 1/20 0.46
MEN1 O00255 1/20 0.45
POLB P06746 1/20 0.45
MAPK1 P28482 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1196073 0.88 LTA4H (0.58) CHRNB4CHRNA3CHRNA7CHRNA10CHRNA9
SCHEMBL7089083 0.81 NPC1 (0.62) CHRNB4CHRNA3CHRNA7CHRNA10CHRNA9
SCHEMBL9983791 0.80 MAPK1 (0.66) CHRNB4CHRNA3CHRNA7CHRNA10CHRNA9
SCHEMBL30041284 0.80 MAPK1 (0.66) CHRNB4CHRNA3CHRNA7CHRNA10CHRNA9
SCHEMBL412385 0.79 RIPK1 (0.57) MAPK1BRAF
SCHEMBL31757556 0.77 CHRNB4 (0.47) CHRNB4CHRNA3CHRNA7CHRNA10CHRNA9
SCHEMBL13554406 0.77 CYP3A4 (0.50) CHRNB4CHRNA3CHRNA7CHRNB2CHRNA4
SCHEMBL3901006 0.75 NPC1 (0.64) CHRNB4CHRNA3CHRNA7CHRNA10CHRNA9
SCHEMBL6769982 0.75 LTA4H (0.58) CHRNB4CHRNA3CHRNA7CHRNA10CHRNA9
SCHEMBL5850255 0.75 NPC1 (0.79) NPC1LTA4HCYP17A1CYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143271-B2 Compounds and methods for kinase modulation, and indications therefor PLEXXIKON INC. (US) 2012-03-27 US disclosed
US-8143271-B2 Compounds and methods for kinase modulation, and indications therefor PLEXXIKON INC. (US) 2012-03-27 US disclosed